Skip to content

Evolus EOLS Cash ratio

Cash ratio at other companies

AbbVie logo
AbbVieABBV
0.2×+0.1×

Other financials

Income statement

See full
Revenue$73.1M+6.7%
Gross profit$48.9M+4.8%
Operating income-$6.8M+54.9%
Net income-$10.7M+43.5%
EPS (diluted)-$0.16+46.7%

Balance sheet

See full
Cash & equivalents$49.8M-26.7%
Total debt$164.9M-4.1%
Total equity-$28.8M-336%
Total assets$220.6M+3.4%

Cash flow

See full
Operating cash flow-$10.0M+36.3%
CapEx$415.0K+30.1%
Free cash flow-$10.4M+35.0%

Valuation

See full
Market cap$470.86M-21.3%
Enterprise value$585.97M-16.6%
P/S1.6×-0.6×

Profitability

See full
Gross margin66.1%-2.4pp
Operating margin-13.7%-1.9pp
Net margin-14.4%-3.3pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×
Current ratio-0.3×

Where this comes from

Calculated from Evolus’s reported figures.

Based on the most recent quarter.

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolus's cash ratio?
Evolus (EOLS) reported cash ratio of 0.7× in Q1 2026.
How has Evolus's cash ratio changed year-over-year?
Evolus's cash ratio decreased by 39.4% year-over-year, from 1.2× to 0.7×.
What is the long-term trend for Evolus's cash ratio?
Over 5 years (2020 to 2025), Evolus's cash ratio has grown at a 4.7% compound annual growth rate (CAGR), from 0.6× to 0.7×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.